ELN Intermediate-Risk Category

**Semantic type:** Intellectual Product

**Definition:** A risk stratification category based on molecular genetic profiling of a subject with acute myeloid leukemia indicating an intermediate chance for relapse following treatment and remission. Subjects in this risk group are recommended to receive conventional consolidation therapy followed by allogeneic hematopoietic stem cell transplantation to achieve remission.

**Synonyms:** - ELN Intermediate Risk Category - ELN Intermediate-Risk - European LeukemiaNet Intermediate Risk - Intermediate